Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
about
Screening: A risk-based framework to decide who benefits from screeningClinical application of DNA ploidy to cervical cancer screening: A review.See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia.High-Grade Cervical Dysplasia After Negative Loop Electrosurgical Excision Procedure.
P2860
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@ast
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@en
type
label
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@ast
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@en
prefLabel
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@ast
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@en
P2093
P2860
P1476
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years
@en
P2093
Barbara Fetterman
Hormuzd A Katki
Julia C Gage
Li C Cheung
Nancy E Poitras
Philip E Castle
Thomas Lorey
Tina Raine-Bennett
Walter K Kinney
P2860
P356
10.1097/LGT.0B013E3182854399
P433
P577
2013-04-01T00:00:00Z